These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8171218)

  • 1. Treatment of pyogenic skin infections with rifaximin cream.
    Palazzini E; Palmerio B
    Riv Eur Sci Med Farmacol; 1993; 15(2):87-92. PubMed ID: 8171218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract.
    Pelosini I; Scarpignato C
    Chemotherapy; 2005; 51 Suppl 1():122-30. PubMed ID: 15855757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
    Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
    Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaximin for the treatment of hepatic encephalopathy.
    Mantry PS; Munsaf S
    Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream.
    Tadini G; Giustini S; Milani M
    Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study.
    Zeng X; Tang XJ; Sheng X; Ni W; Xin HG; Chen WZ; Jiang CF; Lin Y; Shi J; Shi B; Chen YX; Yuan ZL; Xie WF
    J Dig Dis; 2015 Nov; 16(11):665-74. PubMed ID: 26474237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of rifamycin sv used in situ in urologic surgery].
    Patoir G; Lemaire G
    Lille Med; 1976 Jan; 21(1 suppl 1):8-12. PubMed ID: 1256231
    [No Abstract]   [Full Text] [Related]  

  • 8. Use and safety of rifaximin in children with inflammatory bowel disease.
    Muniyappa P; Gulati R; Mohr F; Hupertz V
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):400-4. PubMed ID: 19668011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized openly comparative study between rifaximin suspension versus rifaximin pills for the eradication of Helicobacter pylori.
    Dell'Anna A; Azzarone P; Ferrieri A
    Eur Rev Med Pharmacol Sci; 1999; 3(3):105-10. PubMed ID: 10827812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with terracortril ointment and cream].
    Schimpf A
    Fortschr Med; 1977 Feb; 95(6):382-4. PubMed ID: 138654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study in healthy volunteers of the topical absorption of a 5% rifaximin cream.
    Berlö JA; Debruyne HJ; Gortz JP
    Drugs Exp Clin Res; 1994; 20(5):205-8. PubMed ID: 7875057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-mediated reactions to rifaximin and rifamycin SV and cross-reactivity among rifamycins.
    Antonicelli L; Micucci C; Bilò MB; Manfredi M; Valentini M; Campi P
    Allergy; 2009 Aug; 64(8):1232-3. PubMed ID: 19416136
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifaximin and Helicobacter pylori eradication.
    De Giorgio R; Stanghellini V; Barbara G; Guerrini S; Ferrieri A; Corinaldesi R
    Eur Rev Med Pharmacol Sci; 1997; 1(4):105-10. PubMed ID: 9558774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.
    Prantera C; Lochs H; Campieri M; Scribano ML; Sturniolo GC; Castiglione F; Cottone M
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1117-25. PubMed ID: 16611272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious diarrhea in the aged: controlled clinical trial of rifaximin.
    Della Marchina M; Renzi G; Palazzini E
    Chemioterapia; 1988 Oct; 7(5):336-40. PubMed ID: 3066519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifaximin: new therapeutic indication and future directions.
    Rivkin A; Gim S
    Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
    DuPont HL; Jiang ZD; Ericsson CD; Adachi JA; Mathewson JJ; DuPont MW; Palazzini E; Riopel LM; Ashley D; Martinez-Sandoval F
    Clin Infect Dis; 2001 Dec; 33(11):1807-15. PubMed ID: 11692292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.
    Prantera C; Lochs H; Grimaldi M; Danese S; Scribano ML; Gionchetti P;
    Gastroenterology; 2012 Mar; 142(3):473-481.e4. PubMed ID: 22155172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
    Lauritano EC; Gabrielli M; Scarpellini E; Ojetti V; Roccarina D; Villita A; Fiore E; Flore R; Santoliquido A; Tondi P; Gasbarrini G; Ghirlanda G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009; 13(2):111-6. PubMed ID: 19499846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.